April 11, 2021

PR Headline News

Top Stories Without The Fluff

Johnson & Johnson to buy Momenta for about $6.5 billion

Jakub Porzycki | NurPhoto | Getty Images

Johnson & Johnson said on Wednesday it would buy Momenta Pharmaceuticals for about $6.5 billion in cash to expand into the area of autoimmune disease treatments.

J&J will pay $52.50 for each Momenta share, a 70.4% premium to Tuesday’s closing price.

This story is developing. Please check back for updates.

Source link